SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

RBC Cuts BioMarin Price Target to $60 From $62

RBC Capital Markets maintained its Sector Perform rating. The change follows BioMarin's Q3 2026 report and downward revision to 2026 financial guidance.

BMRN

Related stories